Streetbeat News

Stock Prices

NEE

A significant amount of unusual options activity has been observed for NextEra Energy (NYSE:NEE), with a bearish stance being taken by a majority of investors. The price range targeted by these investors over the last 3 months is between $40.0 and $67.5. The current price of NEE is $52.15, with RSI indicators suggesting the stock may be oversold. Analysts from Morgan Stanley, RBC Capital, BMO Capital, and Mizuho have maintained positive ratings on NextEra Energy, with price targets ranging from $65 to $91.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 2:32 pm

AXP

A large bearish position has been taken on American Express (NYSE:AXP), as observed from publicly available options history. The sentiment among big-money traders is split between 46% bullish and 53% bearish. Whales have been targeting a price range from $135.0 to $200.0 for American Express over the last 3 months. Morgan Stanley maintains an Overweight rating on AXP with a price target of $185, Piper Sandler maintains an Underweight rating with a price target of $150, and RBC Capital upgraded its action to Outperform with a price target of $200.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 2:31 pm

KLAC

KLA (NASDAQ:KLAC) has outperformed the market over the past 20 years by 3.57% on an annualized basis, producing an average annual return of 10.81%. If an investor had bought $100 of KLAC stock 20 years ago, it would be worth $786.48 today.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 2:30 pm

ADM

Archer-Daniels Midland (NYSE:ADM) has outperformed the market over the past 20 years by 1.68% on an annualized basis, producing an average annual return of 8.92%. If an investor had bought $1000 of ADM stock 20 years ago, it would be worth $5,498.51 today.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 2:30 pm

LLY

Eli Lilly and Company (LLY) has announced the acquisition of POINT Biopharma for an aggregate purchase price of approximately $1.4 billion. This has led to a decrease in Lilly's share price.

Portfolio Pulse from Bill Haddad

October 03, 2023 | 2:28 pm

CNXA

Shares of Connexa Sports Technologies were halted on a circuit breaker to the downside, but the stock is now up by 31.2%.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 2:28 pm

AAPL

META

MSFT

QQQ

SPY

The Market Clubhouse Morning Memo recommends monitoring SPY, QQQ, AAPL, MSFT, and META for potential breakouts or reversals. The memo provides detailed analysis and price targets for each of these assets. The analysis is based on a proprietary formula that takes into account price, volume, and options flow. The memo also emphasizes the importance of staying alert and adjusting trading tactics based on the market's pulse.

Portfolio Pulse from RIPS

October 03, 2023 | 2:26 pm

BABA

Alibaba's shares are trading lower due to weakness in Chinese stocks.

Portfolio Pulse from Bill Haddad

October 03, 2023 | 2:23 pm

KITT

Nauticus Robotics Inc (NASDAQ:KITT) has announced a deal to acquire 3D at Depth, Inc. for about $34 million in stock and the assumption of debt of around $4.1 million. The acquisition will enhance KITT's autonomous underwater maritime capabilities and add 11 patents, with an additional 19 pending patents. The deal is expected to close in Q4 2023 and be accretive to KITT's 2024 revenue per share, EPS, and cash flow per share. KITT shares are currently trading lower by 2.51% at $1.7450.

Portfolio Pulse from Lekha Gupta

October 03, 2023 | 2:14 pm

ABNB

ALXO

AZN

DAL

DIS

GME

LLY

MKC

MSFT

NVO

SNY

SPOT

TAK

TGT

Microsoft's CEO criticizes Google's exclusive content deals amid antitrust case. AstraZeneca settles heartburn treatment lawsuit for $425 million. Sanofi and Johnson & Johnson join forces to develop E.coli vaccine. Takeda withdraws lung cancer drug from US after failed trial. Target kicks off holiday shopping season with toys under $25. McCormick stock falls after Q3 earnings. ALX Oncology stock gained over 100% on interim gastric cancer data. Eli Lilly to acquire POINT Biopharma for $1.4B. Disney+ tightens subscription sharing rules. Boeing sets eyes on ambitious 737 output by mid-2025. Novo Nordisk wins weight loss drug patent battle against Viatris. Japan's government boosts Micron with $1.3B subsidy. Airbnb CEO proposes fix for company's foundational cracks. Delta uncovers unauthorized components in jets. Spotify's CEO calls for swift AI regulation overhaul. Movie 'Dumb Money' unpacks GameStop meme stock frenzy.

Portfolio Pulse from Vandana Singh

October 03, 2023 | 2:11 pm